The Foundation
We are working to defeat this disease and achieve a future in which aging is associated with positive experiences.
We are working to defeat this disease and achieve a future in which aging is associated with positive experiences.
I want to help defeat this disease
We talk about Alzheimer's and its impact on those affected and their families.
We believe that only through research will we achieve a future without Alzheimer's.
We help affected families and caregivers with our support programs.
We work towards changing the social perception of the disease through dissemination and public advocacy.
We put Alzheimer's on the political agenda.
We are working to defeat this disease and achieve a future in which aging is associated with positive experiences.
We talk about Alzheimer's and its impact on those affected and their families.
We believe that only through research will we achieve a future without Alzheimer's.
We help affected families and caregivers with our support programs.
We work towards changing the social perception of the disease through dissemination and public advocacy.
Help us continue investigating.
The Barcelonaβeta Brain Research Center (BBRC) is the research center of the Pasqual Maragall Foundation, dedicated to the prevention of Alzheimer's disease and the study of cognitive functions affected by healthy and pathological aging.
We develop our activity through highly collaborative research groups that address Alzheimer's disease from all the perspectives that affect it. Our studies cover areas such as genetics, neuroimaging, fluid biomarkers and risk factors, among many others.
Groups and lines of researchWe make this possible through our research platforms, which are responsible for the efficient collection and use of data from our research projects, as well as the incorporation and maintenance of cutting-edge technology in the field of Alzheimer's.
Research platformsThe Alfa cohort, supported by the “la Caixa” Foundation, is one of the most complex research initiatives with the largest number of participants in the world. Its objective is to characterise the pathophysiology of Alzheimer's disease in the preclinical phase and develop preventive treatments.
This cohort represents a very valuable research platform, providing us with clinical and cognitive data from highly characterized individuals, which feed into most of the Alzheimer's prevention studies we develop at the BBRC.
Meet the Alfa cohort“I will do whatever it takes to help fight Alzheimer’s. I want to prevent my children from having to go through the same thing.”
Alfa Study participant
“I want to help research. I lived through my mother’s illness for 10 years and want to do something.”
Alfa Study participant